South Korea · Delayed Price · Currency is KRW Jeonjinbio Statistics
Total Valuation
Jeonjinbio has a market cap or net worth of KRW 15.94 billion. The enterprise value is 8.89 billion.
| Market Cap | 15.94B |
| Enterprise Value | 8.89B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Jeonjinbio has 9.06 million shares outstanding. The number of shares has increased by 1.27% in one year.
| Current Share Class | 9.06M |
| Shares Outstanding | 9.06M |
| Shares Change (YoY) | +1.27% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.80% |
| Owned by Institutions (%) | n/a |
| Float | 7.85M |
Valuation Ratios
The trailing PE ratio is 958.32.
| PE Ratio | 958.32 |
| Forward PE | n/a |
| PS Ratio | 1.11 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | 15.46 |
| P/OCF Ratio | 9.39 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.23, with an EV/FCF ratio of 8.62.
| EV / Earnings | 534.12 |
| EV / Sales | 0.62 |
| EV / EBITDA | 18.23 |
| EV / EBIT | n/a |
| EV / FCF | 8.62 |
Financial Position
The company has a current ratio of 10.49
| Current Ratio | 10.49 |
| Quick Ratio | 9.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.10% and return on invested capital (ROIC) is -0.62%.
| Return on Equity (ROE) | 0.10% |
| Return on Assets (ROA) | -0.22% |
| Return on Invested Capital (ROIC) | -0.62% |
| Return on Capital Employed (ROCE) | -0.37% |
| Weighted Average Cost of Capital (WACC) | 1.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.79 |
| Inventory Turnover | 8.17 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.32% in the last 52 weeks. The beta is -0.48, so Jeonjinbio's price volatility has been lower than the market average.
| Beta (5Y) | -0.48 |
| 52-Week Price Change | -57.32% |
| 50-Day Moving Average | 2,019.98 |
| 200-Day Moving Average | 2,427.08 |
| Relative Strength Index (RSI) | 43.54 |
| Average Volume (20 Days) | 21,674 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Jeonjinbio had revenue of KRW 14.42 billion and earned 16.64 million in profits. Earnings per share was 1.84.
| Revenue | 14.42B |
| Gross Profit | 3.97B |
| Operating Income | -65.59M |
| Pretax Income | 16.64M |
| Net Income | 16.64M |
| EBITDA | 487.49M |
| EBIT | -65.59M |
| Earnings Per Share (EPS) | 1.84 |
Balance Sheet
The company has 7.06 billion in cash and n/a in debt, with a net cash position of 7.06 billion or 779.06 per share.
| Cash & Cash Equivalents | 7.06B |
| Total Debt | n/a |
| Net Cash | 7.06B |
| Net Cash Per Share | 779.06 |
| Equity (Book Value) | 17.24B |
| Book Value Per Share | 1,902.82 |
| Working Capital | 8.60B |
Cash Flow
In the last 12 months, operating cash flow was 1.70 billion and capital expenditures -667.59 million, giving a free cash flow of 1.03 billion.
| Operating Cash Flow | 1.70B |
| Capital Expenditures | -667.59M |
| Depreciation & Amortization | 553.08M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.03B |
| FCF Per Share | 113.83 |
Margins
Gross margin is 27.53%, with operating and profit margins of -0.45% and 0.12%.
| Gross Margin | 27.53% |
| Operating Margin | -0.45% |
| Pretax Margin | 0.12% |
| Profit Margin | 0.12% |
| EBITDA Margin | 3.38% |
| EBIT Margin | -0.45% |
| FCF Margin | 7.15% |
Dividends & Yields
Jeonjinbio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.27% |
| Shareholder Yield | -1.27% |
| Earnings Yield | 0.10% |
| FCF Yield | 6.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Jeonjinbio has an Altman Z-Score of 12.41 and a Piotroski F-Score of 3.
| Altman Z-Score | 12.41 |
| Piotroski F-Score | 3 |